Quarterly report pursuant to Section 13 or 15(d)

Formation and Reverse Acquisition of Matinas Biopharma Holdings - Formation (Details Textual)

v2.4.0.8
Formation and Reverse Acquisition of Matinas Biopharma Holdings - Formation (Details Textual) (USD $)
 1 Months Ended 9 Months Ended
May 31, 2013
Sep. 30, 2014
Sep. 30, 2013
Formation And Reverse Acquisition [Line Items]      
Stock Issued During Period, Shares, New Issues 7,500,000    
Warrants Issued For Purchase Of Common Stock 3,750,000    
Common Stock To Be Issued Upon Exercise Of Warrants 3,750,000    
Investment Warrants, Exercise Price $ 2.00    
Proceeds from Issuance of Warrants $ 375,000 $ 0 $ 10,000
Stock And Warrants Issued, Price Per Unit 0.10    
Proceeds from Issuance of Common Stock   0 15,000,000
Adam Stern And Entities Owned By Stern [Member]
      
Formation And Reverse Acquisition [Line Items]      
Stock Issued During Period, Shares, New Issues 2,000,000    
Common Stock To Be Issued Upon Exercise Of Warrants 1,000,000    
Proceeds from Issuance or Sale of Equity, Total 375,000    
Third Parties Including Certain Representatives Of Aegis Capital Corp [Member]
      
Formation And Reverse Acquisition [Line Items]      
Stock Issued During Period, Shares, New Issues 5,500,000    
Warrants Issued For Purchase Of Common Stock 2,250,000    
Common Stock To Be Issued Upon Exercise Of Warrants 2,250,000    
Proceeds from Issuance of Warrants 75,000    
Proceeds from Issuance or Sale of Equity, Total 375,000    
Proceeds from Issuance of Common Stock 300,000    
Formation Warrants [Member]
      
Formation And Reverse Acquisition [Line Items]      
Stock Issued During Period, Shares, New Issues 250,000    
Warrants Issued For Purchase Of Common Stock 250,000    
Investment Warrants, Exercise Price $ 2.00    
Proceeds from Issuance or Sale of Equity, Total 10,000    
Issuance Of Warrants Below Fair Value, Lower Price Than Fair Value Per Warrant 0.47    
Issuance Of Equity Instruments Below Fair Value $ 108,316    
Warrants Purchase Price 0.04